These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 16084878

  • 1. Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study.
    Barad D, Kooperberg C, Wactawski-Wende J, Liu J, Hendrix SL, Watts NB.
    Fertil Steril; 2005 Aug; 84(2):374-83. PubMed ID: 16084878
    [Abstract] [Full Text] [Related]

  • 2. Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.
    Chen Z, Maricic M, Bassford TL, Pettinger M, Ritenbaugh C, Lopez AM, Barad DH, Gass M, Leboff MS.
    Arch Intern Med; 2005 Mar 14; 165(5):552-8. PubMed ID: 15767532
    [Abstract] [Full Text] [Related]

  • 3. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
    Jackson RD, Wactawski-Wende J, LaCroix AZ, Pettinger M, Yood RA, Watts NB, Robbins JA, Lewis CE, Beresford SA, Ko MG, Naughton MJ, Satterfield S, Bassford T, Women's Health Initiative Investigators.
    J Bone Miner Res; 2006 Jun 14; 21(6):817-28. PubMed ID: 16753012
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.
    van Geel TA, Geusens PP, Nagtzaam IF, van der Voort DJ, Schreurs CM, Rinkens PE, Dinant GJ.
    Menopause Int; 2007 Sep 14; 13(3):110-5. PubMed ID: 17785036
    [Abstract] [Full Text] [Related]

  • 5. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.
    Yates J, Barrett-Connor E, Barlas S, Chen YT, Miller PD, Siris ES.
    Obstet Gynecol; 2004 Mar 14; 103(3):440-6. PubMed ID: 14990403
    [Abstract] [Full Text] [Related]

  • 6. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study.
    Smoller JW, Pollack MH, Wassertheil-Smoller S, Jackson RD, Oberman A, Wong ND, Sheps D.
    Arch Gen Psychiatry; 2007 Oct 14; 64(10):1153-60. PubMed ID: 17909127
    [Abstract] [Full Text] [Related]

  • 7. Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative study: duration of use and factors associated with discontinuation.
    Ringa V, Varnoux N, Piault S, Bréart G.
    Fertil Steril; 2005 Jun 14; 83(6):1771-9. PubMed ID: 15950650
    [Abstract] [Full Text] [Related]

  • 8. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F, Manson JE, Stampfer MJ.
    J Womens Health (Larchmt); 2006 Jun 14; 15(1):35-44. PubMed ID: 16417416
    [Abstract] [Full Text] [Related]

  • 9. Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women.
    Chan MF, Dowsett M, Folkerd E, Wareham N, Luben R, Welch A, Bingham S, Khaw KT.
    Menopause; 2008 Jun 14; 15(2):332-9. PubMed ID: 17667152
    [Abstract] [Full Text] [Related]

  • 10. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.
    Maturitas; 2006 Sep 20; 55(2):103-15. PubMed ID: 16815651
    [Abstract] [Full Text] [Related]

  • 11. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA, Margolis K, Luepker RV, Arnett DK.
    J Womens Health (Larchmt); 2004 Nov 20; 13(9):975-85. PubMed ID: 15665654
    [Abstract] [Full Text] [Related]

  • 12. Loop diuretic use and fracture in postmenopausal women: findings from the Women's Health Initiative.
    Carbone LD, Johnson KC, Bush AJ, Robbins J, Larson JC, Thomas A, LaCroix AZ.
    Arch Intern Med; 2009 Jan 26; 169(2):132-40. PubMed ID: 19171809
    [Abstract] [Full Text] [Related]

  • 13. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA.
    Climacteric; 2007 Oct 26; 10 Suppl 2():27-31. PubMed ID: 17882669
    [Abstract] [Full Text] [Related]

  • 14. Long-term fracture risk among women with proven endometriosis.
    Melton LJ, Leibson CL, Good AE, Achenbach SJ, Oberg AL, Khosla S.
    Fertil Steril; 2006 Dec 26; 86(6):1576-83. PubMed ID: 17067584
    [Abstract] [Full Text] [Related]

  • 15. Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757].
    Veerus P, Hovi SL, Fischer K, Rahu M, Hakama M, Hemminki E.
    Maturitas; 2006 Sep 20; 55(2):162-73. PubMed ID: 16504428
    [Abstract] [Full Text] [Related]

  • 16. Postmenopausal hormone therapy and migraine headache.
    Misakian AL, Langer RD, Bensenor IM, Cook NR, Manson JE, Buring JE, Rexrode KM.
    J Womens Health (Larchmt); 2003 Dec 20; 12(10):1027-36. PubMed ID: 14709191
    [Abstract] [Full Text] [Related]

  • 17. Does hormone-replacement therapy prevent fractures in early postmenopausal women?
    Randell KM, Honkanen RJ, Kröger H, Saarikoski S.
    J Bone Miner Res; 2002 Mar 20; 17(3):528-33. PubMed ID: 11874244
    [Abstract] [Full Text] [Related]

  • 18. Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000-2005.
    Islam S, Liu Q, Chines A, Helzner E.
    Menopause; 2009 Mar 20; 16(1):77-83. PubMed ID: 18703983
    [Abstract] [Full Text] [Related]

  • 19. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E, Canfell K.
    Am J Epidemiol; 2009 Jul 01; 170(1):24-8. PubMed ID: 19468078
    [Abstract] [Full Text] [Related]

  • 20. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C, Hinke V, Lange S, Fricke R, Botko R, Pfeilschifter J.
    Exp Clin Endocrinol Diabetes; 2005 Oct 01; 113(9):529-33. PubMed ID: 16235155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.